PEG-INTERFERON-α-2A versus PEG-INTERFERON-α-2B in combination with ribavirin in naives patients with chronic hepatitis C and HIV infection

被引：0
|
作者：
Magni, C. [1 ]
Argenteri, B. [1 ]
Capetti, A. F. [1 ]
Corbellino, M. [2 ]
Giani, G.
Giuliani, G. [1 ]
Lombardi, A. [3 ]
Niero, F. [1 ]
Pastecchia, C. [1 ]
Terzi, R. [1 ]
Zanchetta, N. [3 ]
Rizzardini, G. [1 ]
机构：
[1] Luigi Sacco Hosp, Div Infect Dis 1, Milan, Italy
[2] Luigi Sacco Hosp, Clin Infect Dis, Milan, Italy
[3] Luigi Sacco Hosp, Microbiol Unit, Milan, Italy
来源：
INFECTION | 2010年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：89 / 89
页数：1
相关论文
共 50 条
  • [11] PEG-interferon-α-2b/ribavirinFirst report of autoimmune thrombocytopenia: case report
    [J]. Reactions Weekly, 2002, 902 (1) : 10 - 10
  • [12] Dual role of IL-12 in the therapeutic efficacy or failure during combined PEG-Interferon-α2A and ribavirin therapy in patients with chronic hepatitis C
    Araujo, Ana Ruth
    Peruhype-Magalhaes, Vanessa
    Alves Coelho-dos-Reis, Jordana Grazziela
    Viana Chaves, Laura Patricia
    de Lima, Tatiane Amabili
    Diniz Pimentel, Joao Paulo
    de Paula, Lucia
    de Almeida, Carlos Mauricio
    Tarrago, Andrea Monteiro
    Tateno, Adriana
    Levi, Jose Eduardo
    Teixeira-Carvalho, Andrea
    Martins-Filho, Olindo de Assis
    Lira, Edson da Fonseca
    Torres, Katia Luz
    Talhari, Sinesio
    Malheiro, Adriana
    [J]. IMMUNOLOGY LETTERS, 2013, 154 (1-2) : 61 - 69
  • [13] PEG-interferon-α-2b/ribavirinFirst report of ischaemic colitis: case report
    [J]. Reactions Weekly, 2003, 980 (1) : 18 - 18
  • [14] PEG-interferon-α-2b/ribavirinFirst report of lichen planus: case report
    [J]. Reactions Weekly, 2003, 981 (1) : 15 - 15
  • [15] Pegylated interferon alpha 2b (PEG-IFN) plus ribavirin (RBV) versus pegylated interferon alpha 2b for chronic hepatitis C in HIV patients
    Cargnel, A
    Angeli, E
    Mainini, A
    Gubertini, G
    Giorgi, R
    Orlando, G
    Duca, P
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A766 - A766
  • [16] HCV-specific CD8+ cell detection at week 12 of chronic hepatitis C treatment with PEG-interferon-α2b/ribavirin correlates with infection resolution
    Larrubia, Juan-Ramon
    Lokhande, Megha-Uttam
    Moreno-Cubero, Elia
    Garcia-Garzon, Silvia
    Miguel, Joaquin
    Parra-Cid, Trinidad
    Gonzalez-Praetorious, Alejandro
    Perna, Cristian
    Lazaro, Alicia
    Sanz-de-Villalobos, Eduardo
    [J]. CELLULAR IMMUNOLOGY, 2013, 286 (1-2) : 31 - 38
  • [17] PEG-interferon-α2b:: Pharmacokinetics, pharmacodynamics, safety and preliminary efficacy data.
    Glue, P
    Fang, J
    Sabo, R
    Rouzier-Panis, R
    Raffanel, C
    Gupta, SK
    Jacobs, S
    Garaud, JJ
    Albrecht, JK
    [J]. HEPATOLOGY, 1999, 30 (04) : 189A - 189A
  • [18] Response of hepatitis C genotype-4 naive patients to 24 weeks of peg-interferon-α2b/ribavirin or induction-dose interferon-α2b/ribavirin/amantadine:: A non-randomized controlled study
    El-Zayadi, AR
    Attia, M
    Barakat, EMF
    Badran, HM
    Hamdy, H
    El-Tawil, A
    El-Nakeeb, A
    Selim, O
    Saied, A
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (11): : 2447 - 2452
  • [19] HCV-RNA in the fourth week as a predictive factor of sustained virological response (SVR) in genotype 1 hepatitis C patients treated with PEG-interferon-α2b(PEG-IFN-α2b)and ribavirin
    Segadas-Soares, Jorge André
    Villela-Nogueira, Cristiane
    Perez, Renata M.
    Nabuco, Letícia
    Brandao-Mello, Carlos Eduardo
    Coelho, Henrique Sérgio M.
    [J]. HEPATOLOGY, 2006, 44 (04) : 334A - 334A
  • [20] Differential antiviral effect of PEG-interferon-α-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients
    Neumann, A. U.
    Polis, M. A.
    Rozenberg, L.
    Jackson, J. O.
    Reitano, K. N.
    McLaughlin, M.
    Koratich, C.
    Dewar, R. L.
    Masur, H.
    Haagmans, B. L.
    Kottilil, Shyam
    [J]. AIDS, 2007, 21 (14) : 1855 - 1865
12345